Carcinogenesis, mutagenesis, and fertility studies have not been performed.
Norepinephrine bitartrate injection, USP is a sterile, colorless solution for injection intended for intravenous use. It contains the equivalent of 1 mg of norepinephrine base per 1 mL (4 mg/4 mL). It is available as 4 mg/4 mL in single-dose amber glass vials.
Supplied as: 4 mg/4 mL Single-dose Vials in boxes of 10 (NDC 0781-3755-95)
Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].
Store in original carton until time of administration to protect from light. Discard unused portion.
Risk of Tissue Damage
Advise the patient, family, or caregiver to report signs of extravasation urgently [see Warnings and Precautions (5.1)].
Sandoz Inc., Princeton, NJ 08540
Bitartrate Injection, USP
FOR INTRAVENOUS INFUSION ONLY
Warning: Contains Sulfites.
10 x 4 mL Single-Dose Vials
SANDOZ – A Novartis Division
| NOREPINEPHRINE BITARTRATE |
norepinephrine bitartrate injection, solution, concentrate
|Labeler — Sandoz Inc (005387188)|
Revised: 03/2022 Sandoz Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.